151 related articles for article (PubMed ID: 10478515)
1. Seasonal allergic conjunctivitis: overview and treatment update.
Joss JD; Craig TJ
J Am Osteopath Assoc; 1999 Jul; 99(7 Suppl):S13-8. PubMed ID: 10478515
[TBL] [Abstract][Full Text] [Related]
2. Seasonal allergic conjunctivitis.
Joss J; Craig T
Drugs Today (Barc); 1998 Mar; 34(3):259-65. PubMed ID: 15094855
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and tolerability of newer antihistamines in the treatment of allergic conjunctivitis.
Bielory L; Lien KW; Bigelsen S
Drugs; 2005; 65(2):215-28. PubMed ID: 15631542
[TBL] [Abstract][Full Text] [Related]
4. A comparison of the efficacy and tolerability of olopatadine hydrochloride 0.1% ophthalmic solution and cromolyn sodium 2% ophthalmic solution in seasonal allergic conjunctivitis.
Katelaris CH; Ciprandi G; Missotten L; Turner FD; Bertin D; Berdeaux G;
Clin Ther; 2002 Oct; 24(10):1561-75. PubMed ID: 12462286
[TBL] [Abstract][Full Text] [Related]
5. Seasonal and perennial allergic conjunctivitis.
Wong AH; Barg SS; Leung AK
Recent Pat Inflamm Allergy Drug Discov; 2009 Jun; 3(2):118-27. PubMed ID: 19519588
[TBL] [Abstract][Full Text] [Related]
6. A randomized, double-blind, parallel-group comparison of olopatadine 0.1% ophthalmic solution versus placebo for controlling the signs and symptoms of seasonal allergic conjunctivitis and rhinoconjunctivitis.
Abelson MB; Turner D
Clin Ther; 2003 Mar; 25(3):931-47. PubMed ID: 12852709
[TBL] [Abstract][Full Text] [Related]
7. Seasonal and perennial allergic conjunctivitis.
Wong AH; Barg SS; Leung AK
Recent Pat Inflamm Allergy Drug Discov; 2014; 8(2):139-53. PubMed ID: 25000933
[TBL] [Abstract][Full Text] [Related]
8. Comparative evaluation of olopatadine ophthalmic solution (0.1%) versus ketorolac ophthalmic solution (0.5%) using the provocative antigen challenge model.
Deschenes J; Discepola M; Abelson M
Acta Ophthalmol Scand Suppl; 1999; (228):47-52. PubMed ID: 10337433
[TBL] [Abstract][Full Text] [Related]
9. Olopatadine hydrochloride ophthalmic solution for the treatment of allergic conjunctivitis.
Gonzalez-Estrada A; Reddy K; Dimov V; Eidelman F
Expert Opin Pharmacother; 2017 Aug; 18(11):1137-1143. PubMed ID: 28656804
[TBL] [Abstract][Full Text] [Related]
10. Optimal use of topical agents for allergic conjunctivitis.
Mösges R; Hassan HA; Wenzel MR
BioDrugs; 1997 Oct; 8(4):250-64. PubMed ID: 18020517
[TBL] [Abstract][Full Text] [Related]
11. Comparative study of 0.1% olopatadine hydrochloride and 0.5% ketorolac tromethamine in the treatment of seasonal allergic conjunctivitis.
Yaylali V; Demirlenk I; Tatlipinar S; Ozbay D; Esme A; Yildirim C; Ozden S
Acta Ophthalmol Scand; 2003 Aug; 81(4):378-82. PubMed ID: 12859265
[TBL] [Abstract][Full Text] [Related]
12. Management of seasonal allergic conjunctivitis: guide to therapy.
Bielory BP; O'Brien TP; Bielory L
Acta Ophthalmol; 2012 Aug; 90(5):399-407. PubMed ID: 22067457
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the effects of olopatadine ophthalmic solution, 0.2% on the ocular surface of patients with allergic conjunctivitis and dry eye.
Mah FS; O'Brien T; Kim T; Torkildsen G
Curr Med Res Opin; 2008 Feb; 24(2):441-7. PubMed ID: 18167176
[TBL] [Abstract][Full Text] [Related]
14. Olopatadine ophthalmic solution adjunctive to loratadine compared with loratadine alone in patients with active seasonal allergic conjunctivitis symptoms.
Lanier BQ; Gross RD; Marks BB; Cockrum PC; Juniper EF
Ann Allergy Asthma Immunol; 2001 Jun; 86(6):641-8. PubMed ID: 11428736
[TBL] [Abstract][Full Text] [Related]
15. [Application of corticosteroid eye drops for allergic eye diseases in children].
Csorba A; Soproni A; Maneschg O; Nagy ZZ; Szamosi A
Orv Hetil; 2019 Mar; 160(9):329-337. PubMed ID: 30798620
[TBL] [Abstract][Full Text] [Related]
16. Randomized, double-masked comparison of olopatadine ophthalmic solution, mometasone furoate monohydrate nasal spray, and fexofenadine hydrochloride tablets using the conjunctival and nasal allergen challenge models.
Spangler DL; Abelson MB; Ober A; Gotnes PJ
Clin Ther; 2003 Aug; 25(8):2245-67. PubMed ID: 14512132
[TBL] [Abstract][Full Text] [Related]
17. Topical antihistamines, mast cell stabilizers, and dual-action agents in ocular allergy: current trends.
Ben-Eli H; Solomon A
Curr Opin Allergy Clin Immunol; 2018 Oct; 18(5):411-416. PubMed ID: 30020258
[TBL] [Abstract][Full Text] [Related]
18. OTC drugs for seasonal allergies.
Med Lett Drugs Ther; 2019 Apr; 61(1570):57-60. PubMed ID: 31169808
[No Abstract] [Full Text] [Related]
19. A comparison of olopatadine 0.2% ophthalmic solution versus fluticasone furoate nasal spray for the treatment of allergic conjunctivitis.
Rosenwasser LJ; Mahr T; Abelson MB; Gomes PJ; Kennedy K
Allergy Asthma Proc; 2008; 29(6):644-53. PubMed ID: 19063816
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic options in ocular allergic disease.
Hingorani M; Lightman S
Drugs; 1995 Aug; 50(2):208-21. PubMed ID: 8521755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
